Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Invivyd, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 57 | 58 | +1 |
| Shares | 55.9M | 53.5M | −2.39M (−4.3%) |
| Value | $58.7M | $90.9M | +$32.2M (+55.0%) |
New holders (9)
Institutions that held Invivyd, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acuitas Investments, LLC | 208,579 | $354.6K | 0.21% |
| Susquehanna International Group, LLP | 59,840 | $101.7K | 0.00% |
| Jefferies Financial Group Inc. | 53,200 | $90.4K | 0.00% |
| Marquette Asset Management, LLC | 43,028 | $73.1K | 0.02% |
| JustInvest LLC | 20,243 | $34.4K | 0.00% |
| Naples Global Advisors, LLC | 20,000 | $34.0K | 0.00% |
| XTX Topco Ltd | 18,940 | $32.2K | 0.01% |
| Mariner, LLC | 10,239 | $17.4K | 0.00% |
| Group One Trading, L.P. | 1,600 | $2.72K | 0.00% |
Sold out (8)
Institutions that held Invivyd, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BML Capital Management, LLC | 134,696 | $141.4K |
| Y-Intercept (Hong Kong) Ltd | 111,936 | $117.5K |
| Old Mission Capital LLC | 43,316 | $45.5K |
| Balyasny Asset Management LLC | 13,056 | $13.7K |
| Gladius Capital Management LP | 11,910 | $12.5K |
| Citadel Advisors LLC | 5,454 | $5.73K |
| New York State Common Retirement Fund | 447 | $469 |
| State of Wyoming | 225 | $236 |